Cost-Utility Analysis (CUA) of Belimumab (BEL) in the Treatment of Adult Patients with Active, Autoantibody-Positive Systemic Lupus Erythematosus (SLE)

✍ Scribed by Walczak, J.; Kopel, J.; Sołtys, E.; Dziurda, D.

• Book ID: 122218686
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 58 KB
• Volume: 16
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2013.08.359